The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1S,2R)-N-hydroxy-1-ethyl-2-[methyl((4-[(2-methylquinolin-4-yl)methoxy]phenyl}sulfonyl)amino]cyclopentanecarboxamide ID: ALA4100973
PubChem CID: 11856679
Max Phase: Preclinical
Molecular Formula: C26H31N3O5S
Molecular Weight: 497.62
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@]1(C(=O)NO)CCC[C@H]1N(C)S(=O)(=O)c1ccc(OCc2cc(C)nc3ccccc23)cc1
Standard InChI: InChI=1S/C26H31N3O5S/c1-4-26(25(30)28-31)15-7-10-24(26)29(3)35(32,33)21-13-11-20(12-14-21)34-17-19-16-18(2)27-23-9-6-5-8-22(19)23/h5-6,8-9,11-14,16,24,31H,4,7,10,15,17H2,1-3H3,(H,28,30)/t24-,26+/m1/s1
Standard InChI Key: HSFNYQQMBCDKTR-RSXGOPAZSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
8.5455 -9.8164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9622 -10.5330 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.3745 -9.8139 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8190 -9.6955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8179 -10.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5326 -10.9357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5308 -9.2828 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2463 -9.6918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2470 -10.5186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9623 -10.9296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6772 -10.5149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6725 -9.6850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9567 -9.2777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1044 -9.2832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5345 -11.7606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8211 -12.1747 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1057 -11.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1084 -10.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3938 -10.5290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6794 -10.9432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6839 -11.7724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2504 -10.9484 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2535 -11.7734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5931 -12.2609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8509 -13.0444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6759 -13.0415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9278 -12.2559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1748 -11.5413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5850 -10.8256 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3498 -11.5438 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9352 -10.8306 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7915 -12.4704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4006 -12.1810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2116 -11.8836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5343 -10.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
4 14 1 0
6 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
33 17 1 0
20 2 1 0
2 22 1 0
23 22 1 6
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
24 28 1 0
28 29 2 0
28 30 1 0
30 31 1 0
24 32 1 1
21 33 2 0
32 34 1 0
22 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 497.62Molecular Weight (Monoisotopic): 497.1984AlogP: 4.20#Rotatable Bonds: 8Polar Surface Area: 108.83Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.82CX Basic pKa: 5.02CX LogP: 3.81CX LogD: 3.79Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.36Np Likeness Score: -0.64
References 1. Ouvry G, Berton Y, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Chambon S, Comino C, Deprez B, Duvert D, Duvert G, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Pascau J, Pinto A, Polge G, Reitz A, Reversé K, Rosignoli C, Taquet N, Hennequin LF.. (2017) Identification of novel TACE inhibitors compatible with topical application., 27 (8): [PMID:28274635 ] [10.1016/j.bmcl.2017.02.035 ]